Patient Guide: CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in Russia

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 41 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05887011
Status: 🟢 Enrolling Now
Condition: Unresectable /Inoperable Locally Advanced (Stage II-III) NSCLC and Locally Advanced LS-SCLC (Stage I-III)
Phase: Not Specified

Where You Can Participate

This study is available at 41 locations across the country.

Top locations include:
  • • Arkhangelsk,
  • • Balashikha,
  • • Barnaul,
  • • And 38 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in Russia - Join Clinical Trial NCTNCT05887011

How to Join This Clinical Trial - NCTNCT05887011

Learn how to participate in this Not Specified trial studying an investigational therapy for Unresectable /Inoperable Locally Advanced (Stage II-III) NSCLC and Locally Advanced LS-SCLC (Stage I-III). This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Unresectable /Inoperable Locally Advanced (Stage II-III) NSCLC and Locally Advanced LS-SCLC (Stage I-III). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Unresectable /Inoperable Locally Advanced (Stage II-III) NSCLC and Locally Advanced LS-SCLC (Stage I-III)
Treatment Being Tested
Investigational treatment
Study Phase
Not Specified - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05887011 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 41 locations. Find a study site near you:

Clinical Research Site

Arkhangelsk, - Russian Federation

Status: RECRUITING

Clinical Research Site

Balashikha, - Russian Federation

Status: RECRUITING

Clinical Research Site

Barnaul, - Russian Federation

Status: RECRUITING

Clinical Research Site

Chelyabinsk, - Russian Federation

Status: WITHDRAWN

Clinical Research Site

Ekaterinburg, - Russian Federation

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Grozniy, - Russian Federation

Status: RECRUITING

Clinical Research Site

Irkutsk, - Russian Federation

Status: RECRUITING

Clinical Research Site

Ivanovo, - Russian Federation

Status: RECRUITING

Clinical Research Site

Izhevsk, - Russian Federation

Status: WITHDRAWN

Clinical Research Site

Kaluga, - Russian Federation

Status: RECRUITING

And 31 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this Not Specified clinical trial for Unresectable /Inoperable Locally Advanced (Stage II-III) NSCLC and Locally Advanced LS-SCLC (Stage I-III):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships